Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

111.17
-7.0200-5.94%
Post-market: 108.00-3.1700-2.85%19:59 EDT
Volume:2.90M
Turnover:328.82M
Market Cap:6.75B
PE:12.85
High:118.00
Open:117.50
Low:110.81
Close:118.19
Loading ...

Top Research Reports for Novo Nordisk, Coca-Cola & Wells Fargo

Zacks
·
05 Mar

Ensign Group Expands Healthcare Portfolio With Key Acquisitions

Zacks
·
05 Mar

3 Small-Cap Stocks Skating on Thin Ice

StockStory
·
04 Mar

5 Stocks With Recent Price Strength Defying a Weak February

Zacks
·
04 Mar

Jazz Pharmaceuticals plc (JAZZ): Among the Cash-Rich Mid Cap Stocks to Buy Now

Insider Monkey
·
04 Mar

Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?

Zacks
·
04 Mar

4 Stocks Trading Near 52-Week High With More Upside Potential

Zacks
·
03 Mar

New Strong Buy Stocks for March 3rd

Zacks
·
03 Mar

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?

Zacks
·
28 Feb

International Markets and Jazz (JAZZ): A Deep Dive for Investors

Zacks
·
28 Feb

Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.
·
28 Feb

Jazz Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
27 Feb

Wells Fargo Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
27 Feb

Jazz Pharmaceuticals Faces DEI Challenges Amidst Executive Order and Growing Scrutiny

TIPRANKS
·
27 Feb

Jazz Pharmaceuticals Cut to Neutral From Overweight by Cantor Fitzgerald

Dow Jones
·
27 Feb

Jazz downgraded to Neutral at Cantor on oncology strategy ‘head-scratcher’

TIPRANKS
·
27 Feb

Jazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
27 Feb

Jazz Pharmaceuticals Price Target Raised to $176.00/Share From $163.00 by Piper Sandler

Dow Jones
·
27 Feb

Stock Track | Jazz Pharmaceuticals Soars 5.05% on Positive Earnings, Analyst Upgrades

Stock Track
·
27 Feb

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Zacks
·
26 Feb